Maxx Orthopedics’s Revision Knee System Receives FDA 510(k) Clearance

Maxx Orthopedics announced that it has received U.S. Food and Drug Administration 510(k) clearance for its Freedom PCK Components, a revision knee replacement system.

Advertisement

The Freedom PCK combines Maxx’s previously FDA-cleared Freedom Stemmed Tibial Components with patent-pending femoral components and constrained liners to create a bone-conserving, low-profile revision knee system.

 

Maxx Orthopedics is a subsidiary of Maxx Medical, which develops and markets orthopedic medical devices on an international scale.

More Articles on Devices:

Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.